A Danish biotech firm, awarded $12.8 million under a controversial New Jersey tax incentive program to make the move, signed a long-term lease to relocate its U.S. headquarters and establish a research facility at the former campus of Bristol-Myers Squibb in the state's biotechnology hotbed of Plainsboro.